Q3 earnings Feb 6: Canopy Growth (WEED.TO, TSX) market closed Feb 02 2026: watch CAD1.51

Canopy Growth’s Q3 results arrive on Feb 6, 2026, and WEED.TO stock at CAD 1.51 is priced for a balance-sheet test. Investors will focus on revenue trends, cash flow and inventory after the company’s recent recapitalization. The upcoming report could move shares given a thin trading day volume of 941,766.00 and a market cap of CAD 274,428,948.00. We outline the numbers to watch and how results may change the TSX-listed company’s outlook in Canada and abroad.

WEED.TO stock: earnings calendar and key watchpoints

Canopy Growth (WEED.TO) will report third-quarter fiscal 2026 results on 2026-02-06. Watch management commentary on gross margins, operating cash flow and any revenue guidance. One clear metric to watch is EPS, currently -2.67, and the company’s disclosure on one-off items from the recent recapitalization.

WEED.TO stock financials and valuation snapshot

At close, WEED.TO stock traded at CAD 1.51 with a market cap of CAD 274,428,948.00. Key ratios show a negative earnings base (PE -0.57) but attractive price multiples versus book: P/B 0.56 and P/S 0.98. The balance sheet looks liquid with a current ratio of 5.50, cash per share 1.09, and debt to equity 0.35, so the market will weigh cash runway against persistent net losses.

Operational trends, margins and inventory risks for WEED.TO stock

Gross margin is roughly 26.77%, but operating margins are negative and inventory days are long at 183.15 days. High inventory raises markdown risk if demand weakens. Investors should also track sales mix shifts (beverages, edibles, vapes) and international channel progress, which affect margin recovery timing.

WEED.TO stock market reaction and technical view

Price action shows a year high of CAD 4.15 and a year low of CAD 1.09, with the 50-day average at CAD 1.72 and 200-day average at CAD 1.82. RSI sits at 44.95, suggesting no strong trend. Volume today was 941,766.00 versus an average 4,240,872.00, so expect sharper moves when earnings release increases turnover.

Meyka AI rates WEED.TO with a model forecast

Meyka AI rates WEED.TO with a score of 60.20 out of 100 — Grade B, suggestion HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics and analyst signals. Meyka AI’s forecast model projects a quarterly price of CAD 3.82, implying an upside of 152.98% versus the current CAD 1.51. Forecasts are model-based projections and not guarantees.

Earnings strategy and practical price targets for WEED.TO stock

For traders, a short-term earnings play should size positions for volatility and monitor post-report liquidity. Analysts currently show mixed sentiment and no consensus price target. We set scenario price targets: conservative CAD 0.90, base CAD 1.80, and upside CAD 3.50, tied to margin recovery and U.S. regulatory progress. These targets reflect balance-sheet strength and execution risk; they are not investment advice.

Final Thoughts

Key takeaways for WEED.TO stock: Canopy Growth reports Q3 on Feb 6, 2026, and the market has priced the name at CAD 1.51 with a tight intraday range today between CAD 1.48 and CAD 1.51. The report should clarify cash flow trends and inventory strategy after the company’s recapitalization. Valuation metrics show low price-to-book (0.56) and price-to-sales (0.98), but negative EPS (-2.67) keeps risk high. Meyka AI’s forecast model projects a quarterly price of CAD 3.82, an implied upside of 152.98%, highlighting the range of outcomes investors must weigh. Use the earnings release to re-assess exposure, watch trading volume for conviction, and consult updated analyst notes. Meyka AI provides this as one data-driven view via its AI-powered market analysis platform; forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.